Estrella Immunopharma Inc. (ESLA) Live Share Price, Invest From India

Estrella Immunopharma Inc. Stock Performance

as on June 19, 2026 at 2:16 pm IST

Day's Low
Day's High
$0.98
Day's Price Range
$1.03
$0.95
-3.16%
Downside
8.42%
Upside
52 Week's Low
52 Week's High
$0.78
52-Week Price Range
$3.15
$0.95
17.89%
Downside
231.58%
Upside

Estrella Immunopharma Inc. share price movements today

Previous Close: $1.01
Open: $1.03
Volume: 787.5K
Day's Low - High: $0.98 - $1.03
52 Week Low - High: $0.78 - $3.15

Estrella Immunopharma Inc. Historical Returns

1 Month Return: -16.67 %
3 Month Return: -13.64 %
1 Year Return: + 2 %
3 Year Return: 0 %
5 Year Return: 0 %

Estrella Immunopharma Inc. Stock Fundamentals & Key Indicators

Check Estrella Immunopharma Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$40.9M

EPS (TTM)

-0.39

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-268.50%

Estrella Immunopharma Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Estrella Immunopharma Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Estrella Immunopharma Inc.	NA	$40.9M	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$37.7B	57.21%	71.21	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$116.5B	140.42%	27.22	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$63.7B	13.39%	14.85	29.65%	0.58%

Stock Returns calculator for Estrella Immunopharma Inc. Stock including INR - Dollar returns

The Estrella Immunopharma Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Estrella Immunopharma Inc. investment value today

Current value as on today

₹1,11,271

Returns

₹11,271

(+11.27%)

Returns from Estrella Immunopharma Inc. Stock

₹2,151 (+2.15%)

Dollar Impact

₹9,120 (+9.12%)

Indian Investors' Interest in Estrella Immunopharma Inc. Stock

Search interest for Estrella Immunopharma Inc. Stock has decreased by -56% in the last 30 days, reflecting a downward trend in search activity.

Time period: May 23, 2026 to June 22, 2026

Change:-56% versus previous 30 day period

Estrella Immunopharma Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-
Operating Income	-1	0	-3	-3	-2	-5	-4	0	-2
EBITDA	0	0	-3	-3	-2	-5	-4	0	-2
Interest Expense	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-
Income Before Tax	-1	0	-3	-3	-2	-5	-4	0	-2
Income Tax Expense	0	0	0	0	0	0	-	0	-
Net Income	-1	0	-3	-3	-2	-5	-4	0	-2
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Estrella Immunopharma Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Jun 2021	Dec 2021	Jun 2022	Dec 2022	Jun 2023	Dec 2023	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-
Operating Income	0	-	-1	-	-1	-	-7	-13
EBITDA	0	-	-1	-	0	-	-	-13
Interest Expense	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-
Income Before Tax	0	-	-1	-	0	-	-7	-13
Income Tax Expense	0	-	0	-	0	-	-	0
Net Income	0	0	-1	-1	0	0	-7	-13
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Estrella Immunopharma Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	0	-3	-3	-1	-2	-5	-4	0	-2
Operating Cash Flow	-4	0	-2	0	0	0	0	0	-6
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	0	0	0	0	0	1	1	0	7
Change in Cash	-4	0	-2	0	0	0	0	0	0

Estrella Immunopharma Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-1	0	-7	-8	-13
Operating Cash Flow	-1	-1	-16	-7	-1
Investing Cash Flow	-45	36	-	4	-
Financing Cash Flow	5	-35	12	0	2
Change in Cash	4	0	1	-8	0

Global Institutional Holdings in Estrella Immunopharma Inc.

Funds	Holdings
Geode Capital Management, LLC	0.37%
Armistice Capital, LLC	9.53%
Vanguard Group Inc	1.04%
Vanguard Fiduciary Trust Co	0.15%
Renaissance Technologies Corp	0.15%

See all

Insights on Estrella Immunopharma Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 19.7% return, outperforming this stock by 23.7%
NEGATIVE IMPACT
Price Dip
In the last 7 days, ESLA stock has moved down by -10.4%

About Estrella Immunopharma Inc.

Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidate is EB103, which is in Phase I/II clinical trial, for the treatment of diffuse large B-cell lymphoma; EB104, which is in pre-clinical trial, to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia; and EB201, which is in pre-clinical trial, for the treatment of systemic lupus erythematosus. It offers ARTEMIS, a cell receptor platform to develop and commercialize T-cell therapies targeting CD19 and CD22 for the treatment of hematologic malignancies. It has a collaborative agreement with Eureka and Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. was founded in 2006 and is headquartered in EmeryVille, California. Estrella Immunopharma, Inc. is a subsidiary of Eureka Therapeutics, Inc.

Organisation	Estrella Immunopharma Inc.
Headquarters	5858 Horton Street, EmeryVille, CA, United States, 94608
Industry	Biotechnology
CEO	Dr. Cheng Liu Ph.D.
E-voting on shares	Click here to vote

Key Management of Estrella Immunopharma Inc.

Name	Title
Dr. Cheng Liu Ph.D.	CEO, President & Director
Mr. Jiandong Xu	Chief Financial Officer

FAQs

What is Estrella Immunopharma Inc. share price today?

Estrella Immunopharma Inc. share price today is $0.95 as on June 19, 2026 at 8:46 am IST at the close of the market. Estrella Immunopharma Inc. share today touched a day high of $1.03 and a low of $0.98.

What is the 52 week high and 52 week low for Estrella Immunopharma Inc. share?

Estrella Immunopharma Inc. share touched a 52 week high of $3.15 on November 4, 2025 and a 52 week low of $0.78 on July 15, 2025. Estrella Immunopharma Inc. stock price today i.e. June 19, 2026 at 8:46 am IST is closed at $0.95,which is 69.84% down from its 52 week high and 21.79% up from its 52 week low.

What is Estrella Immunopharma Inc.'s market capitalisation today?

Estrella Immunopharma Inc. market capitalisation is $0.00T as on June 19, 2026 at 8:46 am IST.

How to invest in Estrella Immunopharma Inc. Stock (ESLA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Estrella Immunopharma Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Estrella Immunopharma Inc. Shares that will get you 1.5789 shares as per Estrella Immunopharma Inc. share price of $0.95 per share as on June 19, 2026 at 8:46 am IST.

What is the minimum amount required to buy Estrella Immunopharma Inc. Stock (ESLA) from India?

Indian investors can start investing in Estrella Immunopharma Inc. (ESLA) shares with as little as ₹94.31 or $1 (as of June 22, 2026 at 5:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Estrella Immunopharma Inc. stock (as per the Rupee-Dollar exchange rate as on June 22, 2026 at 5:40 am IST). Based on Estrella Immunopharma Inc. share’s latest price of $0.95 as on June 19, 2026 at 8:46 am IST, you will get 10.5263 shares of Estrella Immunopharma Inc.. Learn more about fractional shares .